Great Diamond Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Great Diamond Partners's PFE Position: Q4 2025 in Review
Great Diamond Partners sold out of Pfizer (PFE) in Q4 2025, closing a stake of 8,099 shares — an estimated $206K sold.
Great Diamond Partners first reported a position in PFE in Q4 2019 and held it in 19 quarters. The position peaked at $1.9M in Q4 2019. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Great Diamond Partners reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Great Diamond Partners sold 8,099 Pfizer shares in Q4 2025, an estimated $206K.
- Great Diamond Partners first reported a position in Pfizer in Q4 2019 and held it in 19 quarters.
- Great Diamond Partners's Pfizer position peaked at $1.9M in Q4 2019.
- 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Great Diamond Partners's 13F filing for Q4 2025, filed 6 Feb 2026.